Yaoqin Gong Selected Research

Yaoqin Gong Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 11/2010
5	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
5	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2012
5	Asthma (Bronchial Asthma) 11/2015 - 01/2007
4	Inflammation (Inflammations) 01/2021 - 11/2015
4	Atherosclerosis 11/2015 - 03/2011
3	Obesity 01/2022 - 01/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 02/2015
3	Neoplasm Metastasis (Metastasis) 02/2020 - 10/2012
3	X-Linked Mental Retardation (Mental Retardation, X Linked) 01/2020 - 03/2007
3	Carcinogenesis 07/2016 - 01/2011
3	Muscular Diseases (Myopathy) 06/2013 - 10/2012
2	Insulin Resistance 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2020
2	Colonic Neoplasms (Colon Cancer) 02/2020 - 01/2016
2	Genomic Instability 01/2020 - 04/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2019 - 11/2010
2	Hereditary Spastic Paraplegia 01/2017 - 03/2013
2	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 06/2012
2	Intellectual Disability (Idiocy) 05/2013 - 03/2013
2	Osteosarcoma (Osteogenic Sarcoma) 02/2012 - 03/2009
1	Body Weight (Weight, Body) 01/2022
1	Glioma (Gliomas) 01/2021
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2021
1	Acidosis 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Infections 01/2021
1	Tremor (Tremors) 01/2020
1	Delayed Puberty 01/2020
1	Metabolic Diseases (Metabolic Disease) 11/2019
1	Wounds and Injuries (Trauma) 11/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Glucose Intolerance 06/2017
1	Leukemia 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2015

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
9	Cullin Proteins (Cullins)IBA 01/2021 - 03/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2011
5	Ligases (Synthetase)IBA 01/2021 - 03/2007
5	UbiquitinIBA 01/2021 - 03/2007
5	BerberineIBA 10/2017 - 03/2009
5	AlkaloidsIBA 10/2017 - 03/2009
4	AntioxidantsIBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 07/2015 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 06/2019 - 04/2011
3	CateninsIBA 12/2015 - 04/2015
2	Therapeutic UsesIBA 01/2022 - 10/2017
2	Biological ProductsIBA 01/2022 - 01/2005
2	Superoxides (Superoxide)IBA 01/2022 - 01/2020
2	Tamoxifen FDA LinkGeneric 01/2021 - 01/2015
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 02/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 01/2017
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2013
2	ResveratrolIBA 01/2017 - 11/2010
2	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2017 - 12/2008
2	oxidized low density lipoproteinIBA 11/2015 - 09/2015
2	LipidsIBA 11/2015 - 10/2012
2	p38 Mitogen-Activated Protein KinasesIBA 07/2015 - 02/2012
2	neferineIBA 07/2015 - 02/2012
2	Cysteine (L-Cysteine)FDA Link 07/2015 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 10/2012
2	N-acylmannosamine kinaseIBA 01/2013 - 04/2011
2	AcetylglucosamineIBA 01/2013 - 04/2011
2	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2013 - 04/2011
2	Uridine Diphosphate (UDP)IBA 01/2013 - 04/2011
1	CeramidesIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 01/2021
1	Poly I-CIBA 01/2021
1	Inositol Polyphosphate 5-PhosphatasesIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	RecQ HelicasesIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 03/2020
1	ChromatinIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	matrigelIBA 11/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	nutlin 3IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	niraparibIBA 10/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2017
1	mouse MIRN194 microRNAIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 07/2016
1	InterferonsIBA 07/2016
1	alvocidib (flavopiridol)IBA 01/2016
1	Cyclin-Dependent Kinase 9IBA 01/2016
1	SphingolipidsIBA 11/2015
1	idebenoneIBA 09/2015
1	BenzylisoquinolinesIBA 07/2015
1	liensinineIBA 07/2015
1	isoliensinineIBA 07/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2011
2	Drug Therapy (Chemotherapy) 01/2015 - 01/2011